Wallroth Donald E.

Chief Financial Officer at Molecular Insight Pharmaceuticals, Inc.

Sold, on record
$25k
Dollars the filings state
Form 4 sales
1
Latest May 22, 2009
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. May 22, 2009 2009

    Sold 6,500 shares at $3.78 ($25k)

    Wallroth Donald E., Chief Financial Officer

    Sold 32.5% of holdings ($76k position)13,500 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Wallroth Donald E.
Source
May 22, 2009May 26, 2009Molecular Insight Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale6,500$25k32.5%UnusualSEC